Market Tracker

08/25 5:16pm ET

Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

12.71
Delayed Data
As of Aug 25
 -0.65 / -4.87%
Today’s Change
7.86
Today|||52-Week Range
20.58
-14.35%
Year-to-Date

Today’s Trading

Previous close13.36
Today’s open13.38
Day’s range12.08 - 13.39
Volume2,373,001
Average volume (3 months)533,802
Market cap$945.1M
Dividend yield--
Data as of 4:00pm ET, 08/25/2016

Growth & Valuation

Earnings growth (last year)+30.89%
Earnings growth (this year)+7.42%
Earnings growth (next 5 years)--
Revenue growth (last year)+71.58%
P/E ratioNM
Price/Sales10.45
Price/Book2.49

Competitors

 Today’s
change
Today’s
% change
AVXSAveXis Inc-3.45-8.67%
AMAGAMAG Pharmaceuticals...-0.83-3.34%
XLRNAcceleron Pharma Inc-0.21-0.70%
NTLAIntellia Therapeutic...+0.08+0.38%
Data as of 4:00pm ET, 08/25/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$89.7M
Annual profit (last year)-$83.3M
Net profit margin-92.93%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Class II Director
Craig A. Wheeler
Chief Operating Officer
Matthew P. Ottmer
Corporate headquarters
Cambridge, Massachusetts

Forecasts